AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma
Title:
AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma
Author:
Iavarone, M. Galmozzi, E. De Silvestri, A. Casadei-Gardini, A. Piscaglia, F. Marisi, G. Facchetti, F. Faloppi, L. Ielasi, L. Tovoli, F. Cimino, A. Scartozzi, M. Cascinu, S. Sangiovanni, A. Tinelli, C. Lampertico, P.